More tools:Markets·Screener·Research·Chat

Sana Biotechnology, Inc. Common Stock (SANA) Financial Statements

Sana Biotechnology, Inc. Common Stock
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00N5BMH70
XNAS · usd
3.45▼ 0.40 (-10.39%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close3.85
Day's Range3.40 – 3.83
52-Week Range2.61 – 6.55
Volume5.0M
Avg Volume2.5M
Share Statistics
Shares Outstanding
Employees142
ExchangeXNAS
Listed2021-02-04
Share count as of August 3, 2026
Loading Income Statement…
Key questions about Sana Biotechnology, Inc. Common Stock (SANA)
What is Sana Biotechnology, Inc. Common Stock's Market Cap?
Sana Biotechnology, Inc. Common Stock's Market Cap is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Sana Biotechnology, Inc. Common Stock's Enterprise Value?
Sana Biotechnology, Inc. Common Stock's Enterprise Value is $872.3M, based on as-reported figures from SEC (XBRL) filings.
What is Sana Biotechnology, Inc. Common Stock's EV / EBITDA?
Sana Biotechnology, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Sana Biotechnology, Inc. Common Stock's Net Income (TTM)?
Sana Biotechnology, Inc. Common Stock's Net Income (TTM) is -$211.8M, based on as-reported figures from SEC (XBRL) filings.
What is Sana Biotechnology, Inc. Common Stock's EBITDA?
Sana Biotechnology, Inc. Common Stock's EBITDA is -$207.8M, based on as-reported figures from SEC (XBRL) filings.
What is Sana Biotechnology, Inc. Common Stock's Diluted EPS (TTM)?
Sana Biotechnology, Inc. Common Stock's Diluted EPS (TTM) is -0.71, based on as-reported figures from SEC (XBRL) filings.
What is Sana Biotechnology, Inc. Common Stock's Net Debt?
Sana Biotechnology, Inc. Common Stock's Net Debt is -$160.5M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development
Research and development related success payments and contingent consideration
General and administrative
Impairment of long-lived assets—
Total operating expenses
Loss from operations
Interest income, net
Other income, net
Net loss
Net loss per common share - basic
Net loss per common share - diluted